Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 102.94x is 747% above its 5-year average of 12.15x, near the high end of its 5-year range (-2.39x–102.94x).
As of the fiscal period ended Sunday, December 31, 2023. 104.75% above its 12-month average of 50.27x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): 102.94x.
INTEREST COVERAGE RATIO
102.94x
INTEREST COVERAGE RATIO AVG TTM
50.27x
INTEREST COVERAGE RATIO AVG 3Y
50.27x
INTEREST COVERAGE RATIO AVG 5Y
12.15x
INTEREST COVERAGE RATIO AVG 10Y
-2.32x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+104.75%
CURRENT VS 3Y AVG
+104.75%
CURRENT VS 5Y AVG
+746.97%
CURRENT VS 10Y AVG
+4542.65%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
+1698.37%
vs the sector median at left
SIGA Technologies, Inc.
Market Cap
$235.97M
Interest Coverage Ratio
102.94x
TTM Avg
50.27x
3Y Avg
50.27x
5Y Avg
12.15x
Market Cap
$235.66M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$236.82M
Interest Coverage Ratio
-133.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.08M
Interest Coverage Ratio
N/A
TTM Avg
148.42x
3Y Avg
88.50x
5Y Avg
120.78x
Market Cap
$239.01M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$239.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$232.72M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$231.77M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SIGA Technologies, Inc. (SIGA) | $235.97M | 102.94x | 50.27x | 50.27x | 12.15x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 0.97x | 0.97x | 0.97x | 0.97x |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -133.11x | N/A | N/A | N/A |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | N/A | 148.42x | 88.50x | 120.78x |
| Invivyd, Inc. (IVVD)vs › | $237.57M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.01M | -1.08x | 0.39x | 0.39x | 0.20x |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $232.72M | -1280.37x | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | N/A | N/A | N/A | N/A |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | -8.56x | N/A | N/A | N/A |
Interest Coverage
102.9x
Debt/Equity
0.00
Current Ratio
21.72
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | 102.94x |
| 2022-12-31 | -2.39x |
| 2020-03-31 | -1.33x |
| 2019-12-31 | -0.89x |
| 2019-09-30 | 0.17x |
| 2019-06-30 | -0.43x |
| 2019-03-31 | 0.56x |
| 2018-12-31 | -1.40x |
| 2018-09-30 | 94.00x |
| 2018-06-30 | -0.97x |
| 2018-03-31 | -1.21x |
| 2017-12-31 | -1.29x |
| 2017-09-30 | -1.51x |
| 2017-06-30 | -1.11x |
| 2017-03-31 | -1.18x |
| 2016-12-31 | -2.04x |
| 2016-09-30 | -2.20x |
| 2016-06-30 | -2.17x |
| 2016-03-31 | -2.42x |
| 2015-06-30 | -325.40x |
| 2015-03-31 | -19.89x |
| 2014-12-31 | -203.59x |
| 2014-09-30 | -1728.29x |
| 2014-06-30 | -38.40x |
| 2014-03-31 | -40.04x |
| 2013-12-31 | -39.71x |
| 2013-09-30 | -18.96x |
| 2013-06-30 | -14.97x |
| 2013-03-31 | -15.54x |
